Coffee and Green Tea Consumption and Cardiovascular Disease Mortality Among People With and Without Hypertension.
coffee
cohort study
diet
green tea
hypertension
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
17 01 2023
17 01 2023
Historique:
pubmed:
22
12
2022
medline:
19
1
2023
entrez:
21
12
2022
Statut:
ppublish
Résumé
Background This study was conducted to examine the impacts of coffee and green tea consumption on cardiovascular disease (CVD) mortality among people with severe hypertension. Methods and Results In the JACC (Japan Collaborative Cohort Study for Evaluation of Cancer Risk), 18 609 participants (6574 men and 12 035 women) aged 40 to 79 years at baseline who completed a lifestyle, diet, and medical history questionnaire, and health examinations, were followed up until 2009. We classified the participants into four blood pressure (BP) categories: optimal and normal BP, high-normal BP, grade 1 hypertension, and grade 2-3 hypertension. A Cox proportional hazard model was used to calculate the multivariable hazard ratios with 95% CIs of CVD mortality. During the 18.9 years of median follow-up, a total of 842 CVD deaths were documented. Coffee consumption was associated with an increased risk of CVD mortality among people with grade 2-3 hypertension; the multivariable hazard ratios (95% CI) of CVD mortality were 0.98 (0.67-1.43) for <1 cup/day, 0.74 (0.37-1.46) for 1 cup/day, and 2.05 (1.17-3.59) for ≥2 cups/day, compared with non-coffee drinkers. Such associations were not found among people with optimal and normal, high-normal BP, and grade 1 hypertension. Green tea consumption was not associated with an increased risk of CVD across any BP categories. Conclusions Heavy coffee consumption was associated with an increased risk of CVD mortality among people with severe hypertension, but not people without hypertension and with grade 1 hypertension. In contrast, green tea consumption was not associated with an increased risk of CVD mortality across all categories of BP.
Identifiants
pubmed: 36542728
doi: 10.1161/JAHA.122.026477
pmc: PMC9939061
doi:
Substances chimiques
Tea
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e026477Références
Am J Physiol Endocrinol Metab. 2007 May;292(5):E1378-87
pubmed: 17227956
Diabetes Care. 2008 Mar;31(3):504-7
pubmed: 18070989
Am J Cardiol. 2008 Dec 1;102(11):1502-8
pubmed: 19026304
Vasc Health Risk Manag. 2008;4(5):963-70
pubmed: 19183744
J Nutr. 2004 Jan;134(1):38-42
pubmed: 14704290
Eur J Nutr. 2018 Jun;57(4):1333-1342
pubmed: 28251341
Circulation. 2009 Mar 3;119(8):1116-23
pubmed: 19221216
Hypertension. 2000 Jul;36(1):137-41
pubmed: 10904026
Stroke. 2021 Mar;52(3):957-965
pubmed: 33535784
Front Immunol. 2017 Apr 10;8:433
pubmed: 28443100
Circulation. 2014 Feb 11;129(6):643-59
pubmed: 24201300
Am J Clin Nutr. 2006 Oct;84(4):888-93
pubmed: 17023717
Naunyn Schmiedebergs Arch Pharmacol. 2016 Nov;389(11):1225-1234
pubmed: 27492718
Eur J Epidemiol. 2019 Aug;34(8):731-752
pubmed: 31055709
J Nutr Biochem. 2007 Mar;18(3):179-83
pubmed: 17296491
J Hypertens. 2018 Oct;36(10):1953-2041
pubmed: 30234752
Sci Rep. 2014 Sep 01;4:6251
pubmed: 25176280
J Epidemiol. 2013;23(3):227-32
pubmed: 23583921
N Engl J Med. 2012 May 17;366(20):1891-904
pubmed: 22591295
Eur J Epidemiol. 2019 Oct;34(10):917-926
pubmed: 31392470
J Epidemiol. 2005 Mar;15 Suppl 1:S9-23
pubmed: 15881192
Med Sci Monit. 2007 Feb;13(2):BR40-5
pubmed: 17261979
J Nutr. 2003 Oct;133(10):3275S-84S
pubmed: 14519826
Neurology. 2010 Nov 2;75(18):1583-8
pubmed: 20881275
Am J Clin Nutr. 2011 Oct;94(4):1113-26
pubmed: 21880846